1

News

FDA Update

UPDATE: Treatment of Peripheral Arterial Disease with Paclitaxel-Coated Balloons and Paclitaxel-Eluting Stents Potentially Associated with Increased Mortality - Letter to Health Care Providers

IRSA would like to draw the attention of its members to the following press reserve from the FDA regarding the use of paclitaxel coated balloons and eluting stents in peripheral vascular disease. 

FDA Update